← All Rocket Pharmaceuticals, INC filings

Rocket Pharmaceuticals, INC Form 4 insider transactions

NASDAQ
RCKT
Rocket Pharmaceuticals, INC
Form 4: Rocket Pharmaceuticals Director Gotham Makker Sells 274,000 Shares
Director Gotham Makker sold 274,000 shares of Rocket Pharmaceuticals (RCKT) at a price of $28.4341 on March 21, 2024.
NASDAQ
RCKT
Rocket Pharmaceuticals, INC
Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
John Militello, VP, Principal Accounting Officer, and Interim Principal Financial Officer of Rocket Pharmaceuticals, sold 2,490 shares of common stock on March 21, 2024, to cover tax obligations related to RSU vesting.
NASDAQ
RCKT
Rocket Pharmaceuticals, INC
Form 4: Rocket Pharmaceuticals Executive Exercises Options and Sells Shares
John Militello, VP and Principal Accounting Officer of Rocket Pharmaceuticals, exercised stock options and sold 10,000 shares of common stock on February 29, 2024.
NASDAQ
RCKT
Rocket Pharmaceuticals, INC
Form 4: Rocket Pharmaceuticals' General Counsel, Martin Wilson, Sells 4,100 Shares
Martin Wilson, General Counsel of Rocket Pharmaceuticals, sold 4,100 shares of common stock on February 29, 2024, at an average price of $29.331 per share.